Heart valve patients test two common blood thinners to stop dangerous clots
NCT ID NCT05493657
Summary
This study aims to find the best blood thinner to prevent clots from forming on new artificial heart valves. Researchers will compare aspirin to clopidogrel in 254 patients who have received a transcatheter aortic valve replacement (TAVR) for severe aortic stenosis. All patients will take both medications for 4 weeks, then continue with just one for several months while doctors check for clots using heart scans.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE AORTIC STENOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yonsei University Health System, Severance Hospital
RECRUITINGSeoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.